These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16607209)

  • 1. A physical activity Rx for the hypertensive patient.
    Frost KL; Topp R
    Nurse Pract; 2006 Apr; 31(4):29-37, quiz 37-9. PubMed ID: 16607209
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obesity as a risk factor in the development of hypertensive organ damage].
    Hano T; Nishio I
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():87-91. PubMed ID: 15171347
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arterial hypertension and obesity--a dangerous combination].
    Zakharieva S
    Vutr Boles; 1999; 31(1):28-32. PubMed ID: 10847146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity and hypertension: from physiopathology to treatment].
    Geronooz I; Krzesinski JM
    Rev Med Liege; 2000 Oct; 55(10):921-8. PubMed ID: 11244800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in obesity: is leptin the culprit?
    Simonds SE; Cowley MA
    Trends Neurosci; 2013 Feb; 36(2):121-32. PubMed ID: 23333346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and hypertension.
    El-Atat F; Aneja A; Mcfarlane S; Sowers J
    Endocrinol Metab Clin North Am; 2003 Dec; 32(4):823-54. PubMed ID: 14711064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hypertension and kidney disease in obesity.
    Hall JE; Brands MW; Henegar JR
    Ann N Y Acad Sci; 1999 Nov; 892():91-107. PubMed ID: 10842655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
    Engeli S; Sharma AM
    Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enlarging body of evidence: obesity and chronic kidney disease.
    Chertow GM; Hsu CY; Johansen KL
    J Am Soc Nephrol; 2006 Jun; 17(6):1501-2. PubMed ID: 16672317
    [No Abstract]   [Full Text] [Related]  

  • 10. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines in relation to cardiovascular disease.
    Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
    Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease.
    Navaneethan SD; Fealy CE; Scelsi AC; Arrigain S; Malin SK; Kirwan JP
    Am J Nephrol; 2015; 42(4):274-81. PubMed ID: 26495987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension in obesity].
    Sugiyama T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():484-8. PubMed ID: 15171420
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Delgado Floody P; Caamaño Navarrete F; Ovalle Elgueta H; Concha Díaz M; Jerez Mayorga D; Osorio Poblete A
    Nutr Hosp; 2016 Mar; 33(2):107. PubMed ID: 27238789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome.
    Cicero AF; Derosa G; Bove M; Di Gregori V; Gaddi AV; Borghi C
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):698-704. PubMed ID: 19741540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exogenous constitutional obesity and methods of physical therapy].
    Olefirenko VT; Vasiukova EA; Granovskaia AM; Vinogradova IM
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (4):64-9. PubMed ID: 7027613
    [No Abstract]   [Full Text] [Related]  

  • 17. Leptin and heart sympathetic activity in normotensive obese and non-obese subjects.
    Amador N; Pérez-Luque E; Malacara JM; Guízar JM; Paniagua R; Lara S
    Ital Heart J; 2004 Jan; 5(1):29-35. PubMed ID: 15080578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adipokines in obesity-associated hypertension.
    Vlasova M; Purhonen AK; Jarvelin MR; Rodilla E; Pascual J; Herzig KH
    Acta Physiol (Oxf); 2010 Oct; 200(2):107-27. PubMed ID: 20653609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physical activity and selected adipokines: adiponectin, leptin and resistin].
    Kopff B; Jegier A
    Pol Arch Med Wewn; 2006 Jan; 115(1):73-84. PubMed ID: 17278789
    [No Abstract]   [Full Text] [Related]  

  • 20. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.